Trials / Completed
CompletedNCT02691078
Validation of 99mTc- EDDA - HYNIC -TOC Kits for Diagnosis of Neuroendocrine Tumors
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Latin American Cooperative Oncology Group · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the properties of the image capture test using 99m Tc - HYNIC -TOC EDDA (octreotide labeled with 99mTc) for the diagnosis of neuroendocrine tumors compared to the 111In - DTPA-octreotide.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 99m Tc - HYNIC -TOC EDDA and 111In - DTPA-octreotide | The patient will undercome an PET/CT exam with 99m Tc - HYNIC -TOC EDDA, after 20 days of wash out, the same patient will undercome the same exam with 111In - DTPA-octreotide in order to compare both radiopharmaceuticals |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2018-01-01
- Completion
- 2018-01-10
- First posted
- 2016-02-25
- Last updated
- 2025-02-04
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT02691078. Inclusion in this directory is not an endorsement.